Skip to main content
Premium Trial:

Request an Annual Quote

Delfi Diagnostics: Robert Guigley

Delfi Diagnostics, a developer of liquid biopsy tests for early cancer detection, has appointed Robert Guigley as its chief commercial officer. He most recently served in the same position at Invitae, now part of Laboratory Corporation of America. Prior to that, Guigley was also COO at Ambry Genetics, and before that, he was at Omada Health and Counsyl. He started his pharmaceutical career with AstraZeneca. He holds an MBA with from Boston University and a bachelor's degree in economics from the University of Pittsburgh.